Insights On CONTRACT PHARMA MANUFACTURING

  1. Viral Vectors: The Backbone Of Cell And Gene Therapy 12/16/2025

    Viral vectors are the indispensable backbone of genetic medicine. Learn the fundamental trade-offs and manufacturing strategies for large-scale production of AAV and lentiviral delivery systems.

  2. Tech Transfer Answers: How To Successfully Onshore A Mid-Phase Project 12/16/2025

    Onshoring biomanufacturing operations is an increasingly common decision. While a mid-phase tech transfer from international to domestic CDMO can be complex, the right partner can ensure success.

  3. NGS Bioinformatics Pipelines For Enhanced Viral Vector QC And Analytics 12/15/2025

    Advanced NGS bioinformatics pipelines ensure viral vector integrity, detect contaminants, and predict splicing patterns, enabling precise quality control for safer, more effective gene therapy development.

  4. Enhancing Lentiviral Vector Titre By Limiting Auto-Transduction 12/15/2025

    Limiting auto-transduction with Additive X boosts lentiviral vector titres by 4.2-fold, reduces reintegration events, and optimizes continuous production processes for advanced cell therapy applications.

  5. Doubling Up For Speed In Biomanufacturing 12/12/2025

    Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

  6. CDMO Or No CDMO... That Is The Question 12/12/2025

    Success depends on assessing internal capabilities and knowing when outsourcing can accelerate timelines. Learn how strategic decisions reduce risk, avoid costly delays, and keep your organization competitive.

  7. Choosing The Best mRNA Manufacturing Strategy 12/12/2025

    Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.

  8. CDMOs - Key Collaborators In Streamlining Drug Development 12/12/2025

    Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

  9. 5 Reasons For Outsourcing Chromatography Resin Lifetime Studies 12/12/2025

    Outsourcing resin lifetime studies accelerates timelines, reduces costs, and minimizes risk. Gain expert support, free up resources, and optimize resin performance without tying up your team or equipment.

  10. Is Your Biologics CDMO Transparent? 12/12/2025

    Transparency and collaboration with a CDMO are vital for reducing risk and protecting IP. Discover four essential practices, from clear communication to IP safeguards, that help build trust.